網(wǎng)站地圖 - 關(guān)于我們
您的當(dāng)前位置: 首頁 > 財經(jīng) > 民生 正文

密爾克衛(wèi)亮相CPHI2024 賦能生物醫(yī)藥行業(yè)供應(yīng)鏈

作者:網(wǎng)絡(luò) 時間:2024-06-24 10:51 點擊:
導(dǎo)讀:密爾克衛(wèi)亮相CPHI2024 賦能生物醫(yī)藥行業(yè)供應(yīng)鏈

密爾克衛(wèi)亮相CPHI2024 賦能生物醫(yī)藥行業(yè)供應(yīng)鏈(圖1)

密爾克衛(wèi)亮相CPHI2024 賦能生物醫(yī)藥行業(yè)供應(yīng)鏈(圖2)

密爾克衛(wèi)亮相CPHI2024 賦能生物醫(yī)藥行業(yè)供應(yīng)鏈(圖3)

密爾克衛(wèi)亮相CPHI2024 賦能生物醫(yī)藥行業(yè)供應(yīng)鏈(圖4)

2024年一季度,我國醫(yī)藥產(chǎn)品進(jìn)出口貿(mào)易額達(dá)469.44億美元,未來,我國醫(yī)藥產(chǎn)業(yè)堅持不斷以更高水平參與全球市場合作,追求高質(zhì)量引進(jìn)來和高水平走出去。

In the first quarter of 2024, China's import and export trade volume of pharmaceutical products reached 46.944 billion US dollars. In the future, China's pharmaceutical industry will continue to participate in global market cooperation at a higher level, pursuing high-quality imports and high-level exports.

密爾克衛(wèi)亮相CPHI2024 賦能生物醫(yī)藥行業(yè)供應(yīng)鏈(圖5)

密爾克衛(wèi)亮相CPHI2024 賦能生物醫(yī)藥行業(yè)供應(yīng)鏈(圖6)

密爾克衛(wèi)亮相CPHI2024 賦能生物醫(yī)藥行業(yè)供應(yīng)鏈(圖7)

密爾克衛(wèi)亮相CPHI2024 賦能生物醫(yī)藥行業(yè)供應(yīng)鏈(圖8)

密爾克衛(wèi)亮相CPHI2024 賦能生物醫(yī)藥行業(yè)供應(yīng)鏈(圖9)

為進(jìn)一步提高服務(wù)生物醫(yī)藥行業(yè)客戶的能力,賦能醫(yī)藥產(chǎn)業(yè)供應(yīng)鏈全流程,密爾克衛(wèi)攜專業(yè)供應(yīng)鏈解決方案亮相本次CPHI:

To further improve the ability to serve biopharmaceutical customers and empower the entire import and export supply chain process of the pharmaceutical industry, Milkyway presented professional supply chain solutions in this CPHI:

倉配一體化

warehousing and distribution

密爾克衛(wèi)亮相CPHI2024 賦能生物醫(yī)藥行業(yè)供應(yīng)鏈(圖10)

密爾克衛(wèi)亮相CPHI2024 賦能生物醫(yī)藥行業(yè)供應(yīng)鏈(圖11)

密爾克衛(wèi)亮相CPHI2024 賦能生物醫(yī)藥行業(yè)供應(yīng)鏈(圖12)

密爾克衛(wèi)亮相CPHI2024 賦能生物醫(yī)藥行業(yè)供應(yīng)鏈(圖13)

密爾克衛(wèi)亮相CPHI2024 賦能生物醫(yī)藥行業(yè)供應(yīng)鏈(圖14)

密爾克衛(wèi)亮相CPHI2024 賦能生物醫(yī)藥行業(yè)供應(yīng)鏈(圖15)

全國范圍內(nèi)自有及運營各類高標(biāo)準(zhǔn)倉庫逾60萬平,針對生物醫(yī)藥行業(yè)客戶提供個性定制化的試劑樣品、恒溫冷藏、保稅監(jiān)管等倉儲服務(wù),及配套的零擔(dān)整車及冷鏈運輸。

Milkyway owns and operates more than 600,000 square meters of high-standard chemical warehouses nationwide, providing customized reagent samples, constant temperature and cold storage, bonded supervision and other warehousing services for customers in the pharmaceutical industry, as well as offering related less-than-truckload, truckload and cold chain transportation services.

全球貨代

Global freight forwarder

在中國各大口岸均設(shè)立分支機構(gòu),新加坡、馬來西亞、美國自有操作團隊,可為醫(yī)藥行業(yè)客戶提供主動或被動控溫的國際海運拼箱、海運整箱、空運、鐵路運輸?shù)侥康膰K端客戶的一站式進(jìn)出口物流。作為AEO高級認(rèn)證企業(yè),密爾克衛(wèi)為客戶提供高效便捷的清關(guān)服務(wù)、關(guān)務(wù)咨詢、歸類指導(dǎo)服務(wù)。

Milkyway has set up branches in major ports in China, and has its own operation team in Singapore, Malaysia and the United States. We can provide customers in the pharmaceutical industry with a one-stop import and export logistics solutions of active or passive temperature control of international sea LCL, sea FCL, air freight, rail transportation to the destination country end customers. As an AEO advanced certification enterprise, Milkyway can provide customers with efficient and convenient customs clearance services, customs consulting, classification guidance services.

特種物流

Special logistics

密爾克衛(wèi)運營各類罐式集裝箱5000+臺,可為醫(yī)藥中間體產(chǎn)品提供國內(nèi)公路、鐵路運輸及國際進(jìn)出口海運服務(wù)。

Milkyway operates 5000+ sets of various tank containers, which can provide domestic road and rail transportation and international import and export shipping services for pharmaceutical intermediates products.

采銷物貿(mào)一體化服務(wù)

Integrated procurement, sales, and trade services

各類化學(xué)品從采購,運輸?shù)絺}儲和增值服務(wù)的一站式全供應(yīng)鏈解決方案

One stop full supply chain solution for all kinds of chemicals from procurement, transportation to warehousing and value-added services

本次展會,密爾克衛(wèi)為現(xiàn)場近3,500家專業(yè)展商與預(yù)估100,000人次的專業(yè)觀眾帶來了眾多樂趣橫生的現(xiàn)場活動,專業(yè)銷售團隊也為每一位駐足停留的客人帶來優(yōu)質(zhì)專業(yè)的咨詢服務(wù)。

At this exhibition, Milkyway brought numerous fun filled on-site activities to nearly 3500 professional exhibitors and an estimated 100000 professional visitors. The professional sales team also provided high-quality and professional consulting services to every guest who stayed.

即日起至6月21日,密爾克衛(wèi)將繼續(xù)在CPHI2024的E6館(東六館)F33展位恭候各位朋友的光臨,我們期待與您的線下交流與互動!

From now on to June 21st, Milkyway will continue to wait for you at booth f33 of hall E6 (East Hall 6) of CPHI2024. We look forward to having offline communication and interaction with you!

密爾克衛(wèi)亮相CPHI2024 賦能生物醫(yī)藥行業(yè)供應(yīng)鏈(圖16)

密爾克衛(wèi)亮相CPHI2024 賦能生物醫(yī)藥行業(yè)供應(yīng)鏈(圖17)

【廣告】 (免責(zé)聲明:本文為本網(wǎng)站出于傳播商業(yè)信息之目的進(jìn)行轉(zhuǎn)載發(fā)布,不代表本網(wǎng)站的觀點及立場。本文所涉文、圖、音視頻等資料的一切權(quán)利和法律責(zé)任歸材料提供方所有和承擔(dān)。本網(wǎng)站對此資訊文字、圖片等所有信息的真實性不作任何保證或承諾,亦不構(gòu)成任何購買、投資等建議,據(jù)此操作者風(fēng)險自擔(dān)。) 本文為轉(zhuǎn)載內(nèi)容,授權(quán)事宜請聯(lián)系原著作權(quán)人,如有侵權(quán),請聯(lián)系本網(wǎng)進(jìn)行刪除。

打賞

取消

感謝您的支持,我會繼續(xù)努力的!

掃碼支持
掃碼打賞,你說多少就多少

打開支付寶掃一掃,即可進(jìn)行掃碼打賞哦

相關(guān)推薦:

網(wǎng)友評論:

推薦使用友言、多說、暢言(需備案后使用)等社會化評論插件

Copyright ? 2021 早報網(wǎng) 版權(quán)所有
蘇ICP備2024138443號

蘇公網(wǎng)安備32130202081338號

本網(wǎng)站所刊載信息,不代表早報網(wǎng)觀點。如您發(fā)現(xiàn)內(nèi)容涉嫌侵權(quán)違法立即與我們聯(lián)系客服 106291126@qq.com 對其相關(guān)內(nèi)容進(jìn)行刪除。
早報網(wǎng)登載文章只用于傳遞更多信息之目的,并不意味著贊同其觀點或證實其描述。文章內(nèi)容僅供參考,不構(gòu)成投資建議。投資者據(jù)此操作,風(fēng)險自擔(dān)。
《早報網(wǎng)》官方網(wǎng)站:www.m.shengcaiquan.cn互聯(lián)網(wǎng)違法和不良信息舉報中心
Top 主站蜘蛛池模板: 应城市| 丰县| 县级市| 广丰县| 亳州市| 苍南县| 黄龙县| 满城县| 遂平县| 馆陶县| 冀州市| 东明县| 昭通市| 满城县| 乌兰察布市| 西城区| 鄂尔多斯市| 邛崃市| 调兵山市| 铜鼓县| 临汾市| 肃南| 敖汉旗| 文安县| 永兴县| 荆门市| 故城县| 南部县| 万荣县| 上蔡县| 辉南县| 渝中区| 台中市| 汝南县| 托克逊县| 蚌埠市| 阳西县| 祁连县| 芷江| 阳山县| 宣汉县|